ArticleAnalytical and bioanalytical chemistry2026
Molecular networking, conformal predictions and revised fingerprint-based models for discovering endocrine disruptors in mixtures.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Prioritizing high-risk features is a key step to reduce workload in non-targeted screening (NTS) when identifying environmental contaminants. Machine learning models from the MS2Tox toolbox have shown promise for feature prioritization, but rely heavily on the accuracy of molecular formulas and fingerprint features provided by SIRIUS + CSI:FingerID. In this study, we introduce and evaluate two new approaches-molecular networking (MN) and conformal predictions-to discover unidentified compounds potentially posing endocrine-disrupting activity based on tandem mass spectral similarity. Furthermore, we revised the previously published MS2Tox models, leveraging molecular fingerprints for seven Tox21 Data Challenge endpoints. The fingerprint-based MS2Tox models achieved the lowest false positive rate, 0.35, at 90% recall on the test set, while MN and CP yielded 0.82 and 0.68, respectively. In a case study of transformation products and persistent chemicals in wastewater, these three approaches prioritized 29 features in influent and effluent samples as potentially associated with AhR agonism among 189 LC/HRMS features corresponding to transformation products and persistent chemicals. All candidate structures for prioritized features showed scaffolds related to AhR binding affinity. Three features were identified on level 1, showcasing potential in using combined feature prioritization strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.